S
S. Feinman
Researcher at University of Toronto
Publications - 1
Citations - 205
S. Feinman is an academic researcher from University of Toronto. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 1, co-authored 1 publications receiving 203 citations.
Papers
More filters
Journal ArticleDOI
Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
Uwe Siebert,Uwe Siebert,Gaby Sroczynski,S. Rossol,Jürgen Wasem,U. Ravens-Sieberer,B. M. Kurth,Michael P. Manns,John G. McHutchison,John B. Wong,Wolfgang Greiner,J. M.G. vonderSchulenburg,M. Bullinger,P. Aidelsburger,Franz Hessel,F. Buchner,M. Corzillius,F. H. Anderson,Sanjeev Arora,Bruce R. Bacon,L. Balart,K. G. Benner,M. A. Bigard,H. C. Bodenheimer,M. Bourliere,Christian Bréchot,H. Brunner,S. Caldwell,W. Carey,Robert L. Carithers,G. L. Davis,Jules L. Dienstag,J. Donovan,R. Esteban-Mur,Maria Buti,Gregory T. Everson,S. Feinman,Steven L. Flamm,Peter R. Galle,Robert G. Gish,N. Gitlin,Tobias Goeser,S. Gordon,H. Greten,S. Hadzyiannis,I. Hokeberg,Ira M. Jacobson,Paul Y. Kwo,D. R. LaBrecque,William M. Lee,Stefan Lindgren,K. L. Lindsay,P. Marcellin,P. Marotta,Thomas J. McGarrity,R. Moreno,Timothy R. Morgan,R. Perrillo,M. Poliquin,Thierry Poynard,J. Rakela,R. Reindollar,J. L. Rodriguez-Agullo,R. Rouzier-Panis,V. Rustgi,José-María Sánchez-Tapias,E. R. Schiff,Detlef Schuppan,Morris Sherman,Mitchell L. Shiffman,M. Silva,C. Smith,H. Tanno,C. Trepo,Wolfgang Vogel,Teresa L. Wright,Stefan Zeuzem +76 more
TL;DR: Peginterferon α-2b plus ribavirin should reduce the incidence of liver complications, prolong life, improve quality of life, and be cost effective for the initial treatment of chronic hepatitis C.